估计基于亚麻的高血压治疗对医疗保健的潜在成本节约
Luc Clair1,2, Jared Kashton1, Grant N Pierce1,3,4
1Canadian Centre for Agri-Food Research in Health and Medicine, Albrechtsen Research Centre, St. Boniface Hospital, Winnipeg, MB R2H 2A6, Canada.
Nutrients
|August 29, 2024
概括
每天食用亚麻可以显著降低加拿大的高血压患病率和相关的医疗保健成本. 这项研究估计,通过将亚麻纳入高血压管理策略,可以节省超过9600万加元的潜在成本.
科学领域:
- 心血管健康 心血管健康
- 卫生经济学 卫生经济学
- 营养科学 营养科学
背景情况:
- 高血压是加拿大医疗保健支出的主要驱动因素,原因是直接的医疗费用和其作为其他慢性疾病风险因素的作用.
- 降低高血压患病率对于减轻加拿大医疗保健系统的财务负担至关重要.
- 临床研究表明,亚麻的消费可以降低心压和心压血压.
研究的目的:
- 估计加拿大的潜在医疗保健成本节约,可归因于基于亚麻的高血压治疗.
- 通过饮食干预来分析降低高血压患病率对经济的影响.
主要方法:
- 使用了四个阶段的疾病成本分析.
- 该研究评估了亚麻饮食的可能采用率,其对血压的影响,并使用加拿大卫生测量调查数据估计降低高血压患病率.
- 使用灵敏度分析和蒙特卡洛模拟来解释诸如摄入成功率等参数中的不确定性.
主要成果:
- 该分析预计2020年加拿大可能节省医疗保健成本.
- 最保守的估计显示,潜在的节省额为96,284,344.4加元.
- 该研究量化了将亚麻纳入高血压管理中的经济益处.
结论:
- 在加拿大,亚麻的消费是减少高血压患病率及其相关经济负担的可行策略.
- 实施基于亚麻的干预措施可以在加拿大医疗保健系统中节省大量资金.
- 进一步研究大规模采用和长期影响是有必要的,以充分实现这些经济效益.
更多相关视频
08:49Floral-Dip Transformation of Flax Linum usitatissimum to Generate Transgenic Progenies with a High Transformation Rate
Published on: December 19, 2014
29.2K
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
相关概念视频
01:25Errors occurring during blood pressure monitoring
621
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
621
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
142
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
142